# The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer

> **NCT05502523** · NA · RECRUITING · sponsor: **Thomas Jefferson University** · enrollment: 100 (estimated)

## Conditions studied

- Lung Non-Small Cell Carcinoma
- Stage I Lung Cancer AJCC v8
- Stage II Lung Cancer AJCC v8
- Stage III Lung Cancer AJCC v8

## Interventions

- **PROCEDURE:** Pulmonary Artery-First Surgical Technique
- **PROCEDURE:** Biospecimen Collection

## Key facts

- **NCT ID:** NCT05502523
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-31
- **Primary completion:** 2027-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05502523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05502523, "The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT05502523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*